Market Cap 567.03M
Revenue (ttm) 687.80M
Net Income (ttm) -392.10M
EPS (ttm) N/A
PE Ratio 10.17
Forward PE 13.49
Profit Margin -57.01%
Debt to Equity Ratio 0.14
Volume 541,200
Avg Vol 614,684
Day's Range N/A - N/A
Shares Out 46.40M
Stochastic %K 41%
Beta 1.12
Analysts Hold
Price Target $14.00

Company Profile

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready co...

Industry: Medical Devices
Sector: Healthcare
Phone: 844 428 2667
Website: avanos.com
Address:
5405 Windward Parkway, Suite 100 South, Alpharetta, United States
ZacksResearch
ZacksResearch Sep. 10 at 5:13 PM
$AVNS dropped 22.4% YTD — what's happening? 🩺 Despite strong Q2 product performance and strategic transformation efforts, tariff risks and FX volatility are pressing hard on margins. ⚠️ Understand the risks before investing in AVNS 👉 https://www.zacks.com/stock/news/2749660/reasons-to-retain-avanos-medical-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2749660-body-11833&ADID=SYND_STOCKTWITS_TWEET_2_2749660_BODY_11833
0 · Reply
ZacksResearch
ZacksResearch Sep. 10 at 4:13 PM
$AVNS showing why it deserves a spot in portfolios right now. Solid Q2 results, strong product demand, and ongoing strategic transformation are fueling growth even with tariff and FX headwinds. See the full case for holding AVNS 👉 https://www.zacks.com/stock/news/2749660/reasons-to-retain-avanos-medical-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2749660-teaser-11830&ADID=SYND_STOCKTWITS_TWEET_2_2749660_TEASER_11830
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 10 at 10:44 AM
$AVNS Outstanding article that hits the mark on AVNS's current state. So if you want to refresh your AVNS insights or learn about AVNS from scratch, this is a must read. https://beyondspx.com/quote/AVNS/analysis/avanos-medical-precision-focus-and-innovation-fueling-a-targeted-transformation-nyse-avns
0 · Reply
SignalMap
SignalMap Aug. 23 at 6:26 AM
$AVNS Avanos Medical Inc is a medical device company facing product portfolio transition and margin challenges
0 · Reply
ManosDeDiamante07
ManosDeDiamante07 Aug. 17 at 2:08 AM
$AVNS Get ready and be patient
0 · Reply
SocioCobb
SocioCobb Aug. 15 at 5:14 PM
$AVNS Insider purchase tag 👀
0 · Reply
ZacksResearch
ZacksResearch Aug. 6 at 6:17 PM
$AVNS drops 12.1% after mixed Q2 results — what's going on? 📉 ⚠️ EPS down 50% YoY & adjusted EPS miss by 5.6% 📈 Total revenue up 1.9% YoY, beating estimates 📉 Margin contraction & tariff costs weigh on profitability Understand the risks before investing in Avanos 👉 https://www.zacks.com/stock/news/2674143/avanos-medical-stock-down-as-q2-earnings-miss-estimates-margins-down?cid=sm-stocktwits-2-2674143-body-6476&ADID=SYND_STOCKTWITS_TWEET_2_2674143_BODY_6476
0 · Reply
ZacksResearch
ZacksResearch Aug. 6 at 5:06 PM
$AVNS drops hard on Q2 miss — but is the worst priced in? Earnings missed estimates, margins contracted, and tariff headwinds hit profitability — shares sank 12% on the news. Full breakdown here 👉 https://www.zacks.com/stock/news/2674143/avanos-medical-stock-down-as-q2-earnings-miss-estimates-margins-down?cid=sm-stocktwits-2-2674143-teaser-6424&ADID=SYND_STOCKTWITS_TWEET_2_2674143_TEASER_6424
0 · Reply
Estimize
Estimize Jul. 28 at 11:00 AM
Wall St is expecting 0.15 EPS for $AVNS Q2 [Reporting 08/05 BMO] http://www.estimize.com/intro/avns?chart=historical&metric_name=eps&utm_co
0 · Reply
Estimize
Estimize May. 14 at 10:00 AM
Wall St is expecting 0.15 EPS for $AVNS Q2 [Reporting 08/12 BMO] http://www.estimize.com/intro/avns?chart=historical&metric_name=eps&utm_co
0 · Reply
Latest News on AVNS
Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 1:26 PM EDT - 6 weeks ago

Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Call Transcript


Avanos Medical, Inc. Announces Second Quarter 2025 Results

Aug 5, 2025, 6:30 AM EDT - 6 weeks ago

Avanos Medical, Inc. Announces Second Quarter 2025 Results


Avanos Medical, Inc. (AVNS) Q1 2025 Earnings Call Transcript

May 6, 2025, 2:38 PM EDT - 4 months ago

Avanos Medical, Inc. (AVNS) Q1 2025 Earnings Call Transcript


Avanos Medical, Inc. Announces First Quarter 2025 Results

May 6, 2025, 7:00 AM EDT - 4 months ago

Avanos Medical, Inc. Announces First Quarter 2025 Results


Avanos Medical Inc. (AVNS) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 12:41 PM EST - 7 months ago

Avanos Medical Inc. (AVNS) Q4 2024 Earnings Call Transcript


Avanos Medical Launches New CORGRIP® SR

Nov 5, 2024, 7:00 AM EST - 11 months ago

Avanos Medical Launches New CORGRIP® SR


Avanos Medical Inc. (AVNS) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 3:28 PM EDT - 11 months ago

Avanos Medical Inc. (AVNS) Q3 2024 Earnings Call Transcript


Avanos Medical, Inc. (AVNS) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 1:35 PM EDT - 1 year ago

Avanos Medical, Inc. (AVNS) Q2 2024 Earnings Call Transcript


Avanos Medical, Inc. Announces Second Quarter 2024 Results

Jul 31, 2024, 7:00 AM EDT - 1 year ago

Avanos Medical, Inc. Announces Second Quarter 2024 Results


Avanos Medical, Inc. (AVNS) Q1 2024 Earnings Call Transcript

May 5, 2024, 8:37 AM EDT - 1 year ago

Avanos Medical, Inc. (AVNS) Q1 2024 Earnings Call Transcript


Avanos Medical, Inc. Announces First Quarter 2024 Results

May 2, 2024, 7:00 AM EDT - 1 year ago

Avanos Medical, Inc. Announces First Quarter 2024 Results


Avanos Medical, Inc. (AVNS) Q4 2023 Earnings Call Transcript

Feb 20, 2024, 11:07 AM EST - 1 year ago

Avanos Medical, Inc. (AVNS) Q4 2023 Earnings Call Transcript


Avanos Medical Inc. (AVNS) Q3 2023 Earnings Call Transcript

Nov 4, 2023, 12:02 PM EDT - 2 years ago

Avanos Medical Inc. (AVNS) Q3 2023 Earnings Call Transcript


Avanos Medical, Inc. Announces Third Quarter 2023 Results

Nov 1, 2023, 7:00 AM EDT - 2 years ago

Avanos Medical, Inc. Announces Third Quarter 2023 Results


Avanos Medical Inc. (AVNS) Q2 2023 Earnings Call Transcript

Aug 9, 2023, 11:39 AM EDT - 2 years ago

Avanos Medical Inc. (AVNS) Q2 2023 Earnings Call Transcript


ZacksResearch
ZacksResearch Sep. 10 at 5:13 PM
$AVNS dropped 22.4% YTD — what's happening? 🩺 Despite strong Q2 product performance and strategic transformation efforts, tariff risks and FX volatility are pressing hard on margins. ⚠️ Understand the risks before investing in AVNS 👉 https://www.zacks.com/stock/news/2749660/reasons-to-retain-avanos-medical-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2749660-body-11833&ADID=SYND_STOCKTWITS_TWEET_2_2749660_BODY_11833
0 · Reply
ZacksResearch
ZacksResearch Sep. 10 at 4:13 PM
$AVNS showing why it deserves a spot in portfolios right now. Solid Q2 results, strong product demand, and ongoing strategic transformation are fueling growth even with tariff and FX headwinds. See the full case for holding AVNS 👉 https://www.zacks.com/stock/news/2749660/reasons-to-retain-avanos-medical-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2749660-teaser-11830&ADID=SYND_STOCKTWITS_TWEET_2_2749660_TEASER_11830
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 10 at 10:44 AM
$AVNS Outstanding article that hits the mark on AVNS's current state. So if you want to refresh your AVNS insights or learn about AVNS from scratch, this is a must read. https://beyondspx.com/quote/AVNS/analysis/avanos-medical-precision-focus-and-innovation-fueling-a-targeted-transformation-nyse-avns
0 · Reply
SignalMap
SignalMap Aug. 23 at 6:26 AM
$AVNS Avanos Medical Inc is a medical device company facing product portfolio transition and margin challenges
0 · Reply
ManosDeDiamante07
ManosDeDiamante07 Aug. 17 at 2:08 AM
$AVNS Get ready and be patient
0 · Reply
SocioCobb
SocioCobb Aug. 15 at 5:14 PM
$AVNS Insider purchase tag 👀
0 · Reply
ZacksResearch
ZacksResearch Aug. 6 at 6:17 PM
$AVNS drops 12.1% after mixed Q2 results — what's going on? 📉 ⚠️ EPS down 50% YoY & adjusted EPS miss by 5.6% 📈 Total revenue up 1.9% YoY, beating estimates 📉 Margin contraction & tariff costs weigh on profitability Understand the risks before investing in Avanos 👉 https://www.zacks.com/stock/news/2674143/avanos-medical-stock-down-as-q2-earnings-miss-estimates-margins-down?cid=sm-stocktwits-2-2674143-body-6476&ADID=SYND_STOCKTWITS_TWEET_2_2674143_BODY_6476
0 · Reply
ZacksResearch
ZacksResearch Aug. 6 at 5:06 PM
$AVNS drops hard on Q2 miss — but is the worst priced in? Earnings missed estimates, margins contracted, and tariff headwinds hit profitability — shares sank 12% on the news. Full breakdown here 👉 https://www.zacks.com/stock/news/2674143/avanos-medical-stock-down-as-q2-earnings-miss-estimates-margins-down?cid=sm-stocktwits-2-2674143-teaser-6424&ADID=SYND_STOCKTWITS_TWEET_2_2674143_TEASER_6424
0 · Reply
Estimize
Estimize Jul. 28 at 11:00 AM
Wall St is expecting 0.15 EPS for $AVNS Q2 [Reporting 08/05 BMO] http://www.estimize.com/intro/avns?chart=historical&metric_name=eps&utm_co
0 · Reply
Estimize
Estimize May. 14 at 10:00 AM
Wall St is expecting 0.15 EPS for $AVNS Q2 [Reporting 08/12 BMO] http://www.estimize.com/intro/avns?chart=historical&metric_name=eps&utm_co
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Apr. 28 at 11:49 AM
$AVNS sets Q1 earnings call for May 6 with interim CFO Jason Pickett still at the helm. Investors will be listening closely for signs of stabilization after 2024's brutal -47% ROE and $386M net loss. At 0.69x book value, is this a value trap or turnaround play? https://www.prnewswire.com/news-releases/avanos-medical-inc-to-webcast-conference-call-discussing-first-quarter-2025-financial-results-302439633.html
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Apr. 18 at 8:28 PM
$AVNS leadership shakeup continues: Interim CEO Greiner exits after refusing non-CEO role, gets $2.1M severance + accelerated stock vesting. New interim CFO Pickett steps in - his 3rd role expansion since 2014. Stability concerns mount as execs play musical chairs. https://www.sec.gov/Archives/edgar/data/1606498/000160649825000064/avns-20250414.htm
0 · Reply
ajmrtxl
ajmrtxl Apr. 2 at 5:31 PM
$AVNS's latest data on SqueezeFinder
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 27 at 12:35 PM
Digging AVNS' pain management pivot. Strategic acquisitions like OrthogenRx show they're positioning for growth. Watching closely for Q1 performance. Might add small position if momentum continues. $AVNS looking interesting. fine article: https://beyondspx.com/article/avanos-medical-inc-avns-a-prescription-for-long-term-success
0 · Reply
PenkeTrading
PenkeTrading Mar. 26 at 10:08 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of Avanos Medical Inc. Is that bullish or bearish? $AVNS #RsiOversold #NYSE
0 · Reply
StockAnalyticsAI
StockAnalyticsAI Mar. 24 at 11:21 AM
$AVNS Deep Dive 00:00 – Chapter 1: Business Analysis 05:48 – Chapter 2: Management Evaluation 08:17 - Chapter 3: Financial Analysis 12:08 – Chapter 4: Market Sentiment 14:30 – Chapter 5: Ownership Structure 16:08 – Chapter 6: Risk Assessment 18:37 – Chapter 7: Conclusion https://youtu.be/LDzhEENmzE0?si=UWQnDAC4gC_qH4-9
0 · Reply
LewisDaKat
LewisDaKat Feb. 27 at 1:56 AM
News out $AVNS Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2024 Results https://marketwirenews.com/news-releases/avanos-medical-inc-announces-fourth-quarter-and-full-7703403314403334.html $AVNS
0 · Reply
d_risk
d_risk Feb. 26 at 11:08 PM
$AVNS - Avanos Medical Inc. Common Stock - 10K - Updated Risk Factors The 2025 10-K Risk Factor section for AVNS highlights intense competition, strategic acquisition challenges, AI integration risks, intellectual property protection, climate change impacts, third-party payor pressures, COVID-19 resurgence, sole supplier reliance, restructuring execution risks, China-Taiwan conflict, supply chain disruptions, inflationary pressures, healthcare reform, regulatory changes, Medicare/Medicaid exclusion, Mexico-related risks, product liability, macro-economic challenges, oil and gas price volatility, increased tariffs, government action uncertainty, asset impairment, stock price fluctuations, dividend policy, stockholder dilution, and removal of exclusive forum clause. #Risk https://d-risk.ai/AVNS/10-K/2025-02-26
0 · Reply
OpenOutcrier
OpenOutcrier Feb. 26 at 1:38 PM
$AVNS (-13.2% pre) Avanos Medical: Q4 Earnings Snapshot https://ooc.bz/l/57723
0 · Reply
DonCorleone77
DonCorleone77 Feb. 26 at 1:24 PM
$AVNS Sorry. I transposed two letters in the ticker below. It kinda happens sometimes when you post like a hundred earnings before the market opens. My apologies for any confusion this might have caused.
0 · Reply
YandH
YandH Feb. 20 at 2:16 PM
0 · Reply